Immune activation and depression in the elderly;Immuunactivatie en depressie bij ouderen

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 25, 2008, Pages 1413-1417

  Maas, D W ^a   Westendorp, R G J ^a,b   Van Der Mast, R C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Afd Ouderengeneeskunde ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; ETANERCEPT; MONOAMINE; NEUROTRANSMITTER;

AGING; AUTOIMMUNE DISEASE; DEPRESSION; DRUG EFFECT; GERIATRIC CARE; HEPATITIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ILLNESS BEHAVIOR; INFLAMMATION; NEUROTRANSMISSION; NONHUMAN; PREVALENCE; PSORIASIS; REVIEW; STRESS; SYMPTOMATOLOGY; TUMOR;

AFFECT; AGED; AGING; ANIMALS; ANTIDEPRESSIVE AGENTS; CYTOKINES; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; IMMUNOTHERAPY; MALE; PITUITARY-ADRENAL SYSTEM; PSYCHONEUROIMMUNOLOGY;

EID: 46749098371     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Lyness JM, Heo M, Datto CJ, Have TR ten, Katz IR, Drayer R, et al. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med. 2006;144:496-504.
2. Gallo JJ, Rabins PV, Lyketsos CG, Tien AY, Anthony JC. Depression without sadness. J Am Geriatr Soc. 1997;45:570-8.
3. Angst J, Sellaro R, Merikangas KR. Depressive spectrum diagnoses. Compr Psychiatry. 2000:41(2 Suppl 1):39-47.
4. Devanand DP, Adorno E, Cheng J, Burt T, Pelton GH, Roose SP, et al. Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients. J Affect Disord. 2004;78:259-67.
5. Huang BY, Cornoni-Huntley J, Hays JC, Huntley RR, Galanos AN, Blazer DG. Impact of depressive symptoms on hospitalization risk in community-dwelling older persons. J Am Geriatr Soc. 2000;48: 1279-84.
6. Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. JAMA. 1998;279:1720-6.
7. Vinkers DJ, Stek ML, Gussekloo J, Mast RC van der, Westendorp RG. Does depression in old age increase only cardiovascular mortality? The Leiden 85-plus study. Int J Geriatr Psychiatry. 2004;19:852-7.
8. Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, Beurs E de, et al. The natural history of late-life depression: a 6-year prospective study in the community. Arch Gen Psychiatry. 2002;59:605-11.
9. Stek ML, Exel E van, Tilburg W van, Westendorp RG, Beekman AT. The prognosis of depression in old age: outcome six to eight years after clinical treatment. Aging Ment Health. 2002;6:282-5.
10. Stek ML, Vinkers DJ, Gussekloo J, Mast RC van der, Beekman AT, Westendorp RG. Natural history of depression in the oldest old: population-based prospective study. Br J Psychiatry. 2006;188:65-9.
11. Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307-11.
12. Heun R, Kockler M, Papassotiropoulos A. Distinction of early- and late-onset depression in the elderly by their lifetime symptomatology. Int J Geriatr Psychiatry. 2000;15:1138-42.
13. Lockwood KA, Alexopoulos GS, Gorp WG van. Executive dysfunction in geriatric depression. Am J Psychiatry. 2002;159:1119-26.
14. Kok R. Atypische presentatie van depressies bij ouderen, feit of fictie? Tijdschrift voor Gerontologie en Geriatrie. 2004;35:65-71.
15. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
16. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109(21 Suppl 1):II2-10.
17. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003;61: 76-80.
18. Eikelenboom P, Hoogendijk WJ, Jonker C, Tilburg W van. Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease. J Psychiatr Res. 2002;36:269-80.
19. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, et al. Inflammatory markers and depressed mood in older persons. Biol Psychiatry. 2003;54:566-72.
20. Tiemeier H, Hofman A, Tuijl HR van, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14:103-7.
21. Timmerman L, Zitman FG. Unipolaire depressie. In: Hovens JE, Loonen AJM, Timmerman L, redacteuren. Handboek neurobiologische psychiatric Utrecht: De Tijdstroom; 2004. p. 243-5.
22. Groot JC de, Leeuw FE de, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57:1071-6.
23. Vinkers DJ, Mast RC van der, Stek ML, Westendorp RG, Gussekloo J. De relatie tussen atherosclerose, cognitieve achteruitgang en depressie bij ouderen. Ned Tijdschr Geneeskd. 2006;150:2307-11.
24. Versluis CE, Mast RC van der, Buchem MA van, Bollen EL, Blauw GJ, Eekhof JA, et al. Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease. PROSPER study. Int J Geriatr Psychiatry. 2006;21:375-81.
25. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, et al. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry. 2007;191:212-7.
26. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27:24-31.
27. Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35:298-306.
28. Pucak ML, Kaplin AI. Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression. Int Rev Psychiatry. 2005;17:477-83.
29. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123-37.
30. Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev. 2005;29:891-909.
31. Charlton BG. The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypotheses. 2000;54:126-30.
32. Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse effects of interferon-alpha. CNS Drugs. 2005;19:105-23.
33. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis. Lancet. 2006;367:29-35.
34. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21:374-83.
35. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:201-17.
36. Craddock D, Thomas A. Cytokines and late-life depression. Essent Psychopharmacol. 2006;7:42-52.
37. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry. 1999;4:182-8.
38. Suarez EC, Lewis JG, Krishnan RR, Young KH. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology. 2004;29:1119-28.
39. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5:401-12.
40. Hestad KA, Tonseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19:183-8.
41. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl). 2003;170:429-33.
42. Maes M, Bosmans E, Jongh R de, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997; 9:853-8.
43. Dentino AN, Pieper CF, Rao MK, Currie MS, Harris T, Blazer DG, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 1999;47:6-11.
44. Brambilla F, Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand. 1998;97: 309-13.
45. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005;162:175-7.
46. Vetta F, Ronzoni S, Lupattelli MR, Fabbriconi B, Ficoneri C, Cicconetti P, et al. Tumor necrosis factor-alpha and mood disorders in the elderly. Arch Gerontol Geriatr Suppl. 2001;7:435-42.
47. Biggelaar AH van den, Gussekloo J, Craen AJ de, Frölich M, Stek ML, Mast RC van der, et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol. 2007;42:693-701.
48. Kent S, Bluthé RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci. 1992;13:24-8.